Landiolol Hydrochloride for Injection

[Specification] 12.5mg;50mg

[Indications] Landiolol Hydrochloride for Injection is a short-acting intravenous beta-1 selective blocker. Depending on the applicable national authorization, it is used for the short-term control of ventricular rate in supraventricular tachyarrhythmias and for selected perioperative or other acute settings specified in the approved prescribing information.

[Usage and dosage] Landiolol is administered by intravenous infusion under continuous ECG and blood pressure monitoring. The starting infusion rate, titration increments, maximum rate, and duration depend on the indication and the specific approved product information. Dosage should be titrated according to heart rate, blood pressure, and clinical response. Confirm the exact regimen against the current approved product label before publication.